Obstetrics & Gynecology Email Alerts
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Obstetrics & Gynecology 1989;74:295-298
© 1989 by The American College of Obstetricians and Gynecologists
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by CHRISTMAS, J T
Right arrow Articles by LITTLE, B. B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by CHRISTMAS, J T
Right arrow Articles by LITTLE, B. B.

Concomitant Infection With Neisseria gonorrhoeae and Chlamydia trachomatis in Pregnancy

J T CHRISTMAS, MD, GEORGE D. WENDEL, MD, ROGER E. BAWDON, PhD, RANDAL FARRIS, MD, GARRY CARTWRIGHT, PhD and BERTIS B. LITTLE, PhD

From the Department of Obstetrics and Gynecology, University of Texas Southwestern Medical Center, Dallas; and the Sexually Transmitted Disease Clinic, Dallas County Health Department, Dallas, Texas

Abstract

Gonorrhea is an important marker for endocervical chlamydial infections in nonpregnant women. Concomitant infection rates as high as 50% have been reported. There are few data on concomitant infection rates in pregnant patients. The purpose of this study was to examine the prevalence of endocervical chlamydial infections in pregnant women with gonorrhea. Patients with cervical cultures positive for Neisseria gonorrhoeae at their initial prenatal visit had endocervical specimens for Chlamydia trachomatis culture obtained before anti-gonorrheal therapy. Control patients were selected at random from the same prenatal population. The prevalence of C trachomatis in patients with gonorrhea was significantly greater than that in the control population (46 versus 5%; P<.001). Patients with gonorrhea were younger, less often married, and more often black than the control population, but these demographic differences did not account for the large difference in the chlamydial prevalence. Erythromycin 500 mg four times daily provided an excellent cure rate without intolerable side effects. Pregnant patients being evaluated or treated for gonorrhea should also be considered at high risk for concomitant cervical chlamydial infection. (Obstet Gynecol 74: 295, 1989)




This article has been cited by other articles:


Home page
ANN INTERN MEDHome page
S. B. Lyss, M. L. Kamb, T. A. Peterman, J. S. Moran, D. R. Newman, G. Bolan, J. M. Douglas Jr., M. Iatesta, C K. Malotte, J. M. Zenilman, et al.
Chlamydia trachomatis among Patients Infected with and Treated for Neisseria gonorrhoeae in Sexually Transmitted Disease Clinics in the United States
Ann Intern Med, August 5, 2003; 139(3): 178 - 185.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1989 by the American College of Obstetricians and Gynecologists.